Labeler
Ingenus Pharmaceuticals, LLC NDC Codes
Ingenus Pharmaceuticals, LLC lists 142 finished drug products in the FDA NDC Directory under NDC labeler code 50742.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Diltiazem Hydrochloride, Fentanyl, Pramipexole dihydrochloride, estrogens, conjugated, Buprenorphine, Buprenorphine and Naloxone, Leucovorin Calcium, Nicotine Transdermal System, prednisolone sodium phosphate ODT, Oxcarbazepine, Carbamazepine, Metolazone, Mexiletine Hydrochloride, Tizanidine Hydrochloride, Albuterol Sulfate
- Active ingredients
- Diltiazem hydrochloride, Fentanyl, Pramipexole dihydrochloride, Estrogens, Conjugated, Buprenorphine, Buprenorphine hydrochloride, Naloxone hydrochloride, Leucovorin calcium, Nicotine, Prednisolone sodium phosphate, Oxcarbazepine, Carbamazepine
- NDC labeler codes
- 50742
- Strengths (from the 100 most recently listed products)
- Diltiazem hydrochloride 120 mg/1; Phenobarbital 16.2 mg/5mL; Hyoscyamine sulfate .1037 mg/5mL; Atropine sulfate .0194 mg/5mL; Scopolamine hydrobromide .0065 mg/5mL; Nicotine 7 mg/24h; Nicotine 14 mg/24h; Nicotine 21 mg/24h; Estrogens, Conjugated .3 mg/1; Estrogens, Conjugated .45 mg/1; Estrogens, Conjugated .625 mg/1; Estrogens, Conjugated .9 mg/1; Estrogens, Conjugated 1.25 mg/1; Prednisolone sodium phosphate 10 mg/1; Prednisolone sodium phosphate 15 mg/1; Prednisolone sodium phosphate 30 mg/1; Dehydrated alcohol 5 mL/5mL; Diltiazem hydrochloride 60 mg/1; Diltiazem hydrochloride 90 mg/1; Formoterol fumarate .02 mg/2mL
- Dosage forms
- Tablet, Patch, Extended release, Tablet, Extended release, Tablet, Film coated, Capsule, Extended release, Capsule, Solution, Solution/ drops, Film, Patch, Tablet, Orally disintegrating, Elixir, Tablet, Film coated, Extended release, Injection, Solution, Tablet, Coated
- Routes
- Oral, Transdermal, Respiratory (Inhalation), Ophthalmic, Buccal, Sublingual, Percutaneous, Nasal
- Drug classes (FDA established)
- Partial Opioid Agonist, Estrogen, Calcium Channel Blocker, Opioid Agonist, Nonergot Dopamine Agonist, Anticholinergic, Progestin, Corticosteroid, beta2-Adrenergic Agonist, Thiazide-like Diuretic, Opioid Antagonist, Folate Analog, Cholinergic Nicotinic Agonist, Anti-epileptic Agent, Mood Stabilizer, beta-Adrenergic Blocker, Cholinergic Muscarinic Antagonist, Antiarrhythmic, Central alpha-2 Adrenergic Agonist, Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker, Progestin-containing Intrauterine System, Nonsteroidal Anti-inflammatory Drug, Benzodiazepine, Dihydropyridine Calcium Channel Blocker, Cytoprotective Agent, Prostaglandin Analog, Bile Acid Sequestrant, Aminosalicylate, Bismuth, Nitroimidazole Antimicrobial, Tetracycline-class Antimicrobial, Carbonic Anhydrase Inhibitor, Kinase Inhibitor, Serotonin-1b and Serotonin-1d Receptor Agonist, Arteriolar Vasodilator, Nitrate Vasodilator, Muscle Relaxant, Alkaloid
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 150 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Nicotine Transdermal System | Nicotine 7 mg/24h | PatchTransdermal | 50742-668 | 50742-0668-0750742-0668-14 | — |
| Nicotine Transdermal System | Nicotine 14 mg/24h | PatchTransdermal | 50742-669 | 50742-0669-0750742-0669-1450742-0669-28 | — |
| Nicotine Transdermal System | Nicotine 21 mg/24h | PatchTransdermal | 50742-670 | 50742-0670-0750742-0670-1450742-0670-28 | — |
| estrogens, conjugated | Estrogens, Conjugated .3 mg/1 | Tablet, Film coatedOral | 50742-387 | 50742-0387-0150742-0387-10 | — |
| estrogens, conjugated | Estrogens, Conjugated .45 mg/1 | Tablet, Film coatedOral | 50742-388 | 50742-0388-0150742-0388-10 | — |
| estrogens, conjugated | Estrogens, Conjugated .625 mg/1 | Tablet, Film coatedOral | 50742-389 | 50742-0389-0150742-0389-10 | — |
| estrogens, conjugated | Estrogens, Conjugated .9 mg/1 | Tablet, Film coatedOral | 50742-390 | 50742-0390-0150742-0390-10 | — |
| estrogens, conjugated | Estrogens, Conjugated 1.25 mg/1 | Tablet, Film coatedOral | 50742-391 | 50742-0391-0150742-0391-10 | — |
| prednisolone sodium phosphate ODTprednisolone sodium phosphate | Prednisolone sodium phosphate 10 mg/1 | Tablet, Orally disintegratingOral | 50742-383 | 50742-0383-12 | — |
| prednisolone sodium phosphate ODTprednisolone sodium phosphate | Prednisolone sodium phosphate 15 mg/1 | Tablet, Orally disintegratingOral | 50742-384 | 50742-0384-12 | — |
| prednisolone sodium phosphate ODTprednisolone sodium phosphate | Prednisolone sodium phosphate 30 mg/1 | Tablet, Orally disintegratingOral | 50742-385 | 50742-0385-12 | — |
| Dehydrated Alcohol | Dehydrated alcohol 5 mL/5mL | Injection, SolutionPercutaneous | 50742-539 | 50742-0539-10 | — |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 60 mg/1 | Capsule, Extended releaseOral | 50742-564 | 50742-0564-0150742-0564-05 | — |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 90 mg/1 | Capsule, Extended releaseOral | 50742-565 | 50742-0565-0150742-0565-05 | — |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 120 mg/1 | Capsule, Extended releaseOral | 50742-566 | 50742-0566-0150742-0566-05 | — |
| Formoterol Fumarate | Formoterol fumarate .02 mg/2mL | SolutionRespiratory (Inhalation) | 50742-394 | 50742-0394-3050742-0394-60 | — |
| Oxcarbazepine | Oxcarbazepine 150 mg/1 | Tablet, Extended releaseOral | 50742-611 | 50742-0611-01 | — |
| Oxcarbazepine | Oxcarbazepine 300 mg/1 | Tablet, Extended releaseOral | 50742-612 | 50742-0612-01 | — |
| Oxcarbazepine | Oxcarbazepine 600 mg/1 | Tablet, Extended releaseOral | 50742-613 | 50742-0613-01 | — |
| Hemiclorchlorthalidone | Chlorthalidone 12.5 mg/1 | TabletOral | 50742-285 | 50742-0285-3050742-0285-90 | — |
| Arformoterol Tartrate | Arformoterol tartrate 15 ug/2mL | SolutionRespiratory (Inhalation) | 50742-395 | 50742-0395-3050742-0395-60 | — |
| Fentanyl | Fentanyl 87.5 ug/h | Patch, Extended releaseTransdermal | 50742-555 | 50742-0555-05 | — |
| Fentanyl | Fentanyl 62.5 ug/h | Patch, Extended releaseTransdermal | 50742-553 | 50742-0553-05 | — |
| Fentanyl | Fentanyl 37.5 ug/h | Patch, Extended releaseTransdermal | 50742-551 | 50742-0551-05 | — |
| Fentanyl | Fentanyl 12 ug/h | Patch, Extended releaseTransdermal | 50742-549 | 50742-0549-05 | — |
| Fentanyl | Fentanyl 25 ug/h | Patch, Extended releaseTransdermal | 50742-550 | 50742-0550-05 | — |
| Mesna | Mesna 400 mg/1 | Tablet, Film coatedOral | 50742-354 | 50742-0354-01 | — |
| Fentanyl | Fentanyl 50 ug/h | Patch, Extended releaseTransdermal | 50742-552 | 50742-0552-05 | — |
| Fentanyl | Fentanyl 75 ug/h | Patch, Extended releaseTransdermal | 50742-554 | 50742-0554-05 | — |
| Fentanyl | Fentanyl 100 ug/h | Patch, Extended releaseTransdermal | 50742-556 | 50742-0556-05 | — |
| Tafluprost | Tafluprost .015 mg/mL | Solution/ dropsOphthalmic | 50742-339 | 50742-0339-30 | — |
| Colestipol Hydrochloride | Colestipol hydrochloride 1 g/1 | Tablet, Film coatedOral | 50742-284 | 50742-0284-12 | — |
| Albuterol Sulfate | Albuterol sulfate .63 mg/3mL | SolutionRespiratory (Inhalation) | 50742-392 | 50742-0392-25 | — |
| Albuterol Sulfate | Albuterol sulfate 1.25 mg/3mL | SolutionRespiratory (Inhalation) | 50742-393 | 50742-0393-25 | — |
| Mesalamine | Mesalamine .375 g/1 | Capsule, Extended releaseOral | 50742-371 | 50742-0371-12 | — |
| Ivabradine | Ivabradine hydrochloride 5 mg/1 | Tablet, Film coatedOral | 50742-362 | 50742-0362-60 | — |
| Ivabradine | Ivabradine hydrochloride 7.5 mg/1 | Tablet, Film coatedOral | 50742-363 | 50742-0363-60 | — |
| Buprenorphine | Buprenorphine 5 ug/h | Patch, Extended releaseTransdermal | 50742-372 | 50742-0372-04 | — |
| Buprenorphine | Buprenorphine 7.5 ug/h | Patch, Extended releaseTransdermal | 50742-373 | 50742-0373-04 | — |
| Buprenorphine | Buprenorphine 10 ug/h | Patch, Extended releaseTransdermal | 50742-374 | 50742-0374-04 | — |
| Buprenorphine | Buprenorphine 15 ug/h | Patch, Extended releaseTransdermal | 50742-375 | 50742-0375-04 | — |
| Buprenorphine | Buprenorphine 20 ug/h | Patch, Extended releaseTransdermal | 50742-376 | 50742-0376-04 | — |
| Buprenorphine and Naloxone | Buprenorphine hydrochloride 8 mg/1; Naloxone hydrochloride 2 mg/1 | FilmBuccal, Sublingual | 50742-364 | 50742-0364-30 | — |
| Buprenorphine and Naloxone | Buprenorphine hydrochloride 12 mg/1; Naloxone hydrochloride 3 mg/1 | FilmBuccal, Sublingual | 50742-365 | 50742-0365-30 | — |
| Buprenorphine and Naloxone | Buprenorphine hydrochloride 2 mg/1; Naloxone hydrochloride .5 mg/1 | FilmBuccal, Sublingual | 50742-397 | 50742-0397-30 | — |
| Buprenorphine and Naloxone | Buprenorphine hydrochloride 4 mg/1; Naloxone hydrochloride 1 mg/1 | FilmBuccal, Sublingual | 50742-398 | 50742-0398-30 | — |
| Carbamazepine | Carbamazepine 100 mg/1 | Tablet, Extended releaseOral | 50742-257 | 50742-0257-01 | — |
| Carbamazepine | Carbamazepine 200 mg/1 | Tablet, Extended releaseOral | 50742-258 | 50742-0258-01 | — |
| Carbamazepine | Carbamazepine 400 mg/1 | Tablet, Extended releaseOral | 50742-259 | 50742-0259-01 | — |
| Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride | Bismuth subcitrate potassium 140 mg/1 + 2 more ingredients | CapsuleOral | 50742-283 | 50742-0283-13 | — |
Ingenus Pharmaceuticals, LLC: common questions
- What is Ingenus Pharmaceuticals, LLC's NDC labeler code?
- 50742. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Ingenus Pharmaceuticals, LLC?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.